Analyst Profile

Followed by 312 followers
.
Liisa Bayko

Liisa Bayko

Evercore ISI
Wall Street Analyst
#1,160 out of 8,141 Wall Street Analysts
#2,429 out of 24,284 experts

Success Rate

45%
135 out of 303 transactions made a profit

Average Return

+7.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Liisa Bayko's trades since 2009 and holding each position for 1 Year would result in 44.55% of your transactions generating a profit, with an average return of 7.5% per rating.

Stock Rating Distribution

420Ratings
80.24% Buy
15.95% Hold
3.81% Sell
Distribution of Liisa Bayko's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Madrigal
(MDGL)
Rating:Buy
Date:Jan 03, 2017 - Jan 03, 2018
Return:+519.70%
The most profitable rating made by Liisa Bayko

Liisa Bayko's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
VPHM
Viropharma
May 18, 2009
Hold
Downgraded
1Ratings
0.00%
~ATHN
Athenahealth
Dec 04, 2009
Buy
Reiterated
1Ratings
0%
-9.50%
SVNTQ
Savient Pharmaceuticals
Nov 11, 2011
Sell
Downgraded
1Ratings
100%
+57.80%
SLXP
Salix
Feb 29, 2012
Hold
Reiterated
2Ratings
100%
+56.60%
OPTR
Optimer Pharma
Apr 09, 2012
Buy
Reiterated
1Ratings
100%
+6.70%
IDIX
Idenix Pharma
Apr 30, 2012
Hold
Upgraded
1Ratings
0.00%
Anthera Pharmaceuticals
Jun 28, 2012
Hold
Downgraded
1Ratings
0.00%
Dynavax
Jun 10, 2013
Hold
Downgraded
2Ratings
0%
-67.50%
TSRX
Trius Therap
Jul 31, 2013
Hold
Downgraded
1Ratings
0.00%
ITMN
InterMune
Aug 26, 2014
Hold
Downgraded
4Ratings
67%
+97.80%
List of latest recommendations made by Liisa Bayko. Click to expand and see Liisa Bayko's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >